Cold Versus Warm Tumescent Solution in Arm Liposculpture
2 other identifiers
interventional
52
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate whether the temperature of tumescent solution (cold vs. warm) affects postoperative outcomes in adults undergoing arm liposculpture. The study includes men and women aged 18-60 years with certain body complexity, however no obese patients are allowed to enter the study. All patients are undergoing bilateral arm liposculpture as part of body contouring procedures. The main questions it aims to answer are:
- Does using a cold tumescent solution reduce postoperative bruising compared to a warm solution?
- Does a cold tumescent solution reduce postoperative inflammation compared to a warm solution?
- How does solution temperature affect the quality of fat samples collected during liposuction? Researchers will compare the cold tumescent solution group to the warm tumescent solution group to determine whether a lower temperature provides benefits in terms of reduced bruising, inflammation, and improved fat quality. Participants will:
- Receive either a cold (4°C) or warm (room temperature) tumescent solution in each arm before liposuction.
- Undergo fat emulsification with VASER technology.
- Have one arm treated with Power-Assisted Liposuction (PAL) and the other with Conventional Suction-Assisted Liposuction (SAL).
- Have liposuction fat samples collected for analysis of fat content, blood content, and overall fat quality.
- Be monitored for bruising and inflammation on Days 1, 3, and 7 using an image analyzing software and arm circumference measurements.
- Complete a satisfaction survey 30 days after surgery. Safety considerations include monitoring core temperature and using external warming devices if needed to prevent hypothermia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedFirst Submitted
Initial submission to the registry
March 4, 2025
CompletedFirst Posted
Study publicly available on registry
March 10, 2025
CompletedMarch 11, 2025
March 1, 2025
1.3 years
March 4, 2025
March 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Ecchymosis
1\. Postoperative Bruising: Assessed using ImageJ software to quantify areas of bruising at Days 1, 3, and 7 postoperative.
7 days
Edema/inflammation
2\. Inflammation: Measured via arm circumference on Days 1, 3, and 7.
7 days
Pain score
3\. Postoperative pain: Scoring system using the visual analogue scale. From 1 to 10 at each time point: immediately after surgery, 1 ,3 and 7 days postoperative.
7 days
Secondary Outcomes (2)
Lipocrit evaluation
6 hours
Patient satisfaction
30 days
Study Arms (2)
Cold tumescent solution
EXPERIMENTAL1\. Cold Tumescent Solution Group: Infiltration of tumescent solution at 4°C. Composition of tumescent solution: 1000 ml of Ringer's lactate + 7 ml of 2% Lidocaine without Epinephrine + 1 mg of Epinephrine + 250 mg of Tranexamic Acid.
Warm tumescent solution
PLACEBO COMPARATOR2\. Warm Tumescent Solution Group: Infiltration of tumescent solution at room temperature. Composition of tumescent solution: 1000 ml of Ringer's lactate + 7 ml of 2% Lidocaine without Epinephrine + 1 mg of Epinephrine + 250 mg of Tranexamic Acid.
Interventions
Infiltration of cold tumescent solution at 4 C for lipoplasty.
Infiltration of warm tumescent solution at body temperature for lipoplasty.
Infiltration of tumescent solution in both arms, VASER fat emulsification then power-assisted liposuction of the arms.
Eligibility Criteria
You may qualify if:
- Adults aged 18-60 years.
- Body mass index between 18 and 30.
- Patients scheduled for bilateral arm liposculpture together with other body contouring procedures.
- Able to provide informed consent.
You may not qualify if:
- History of coagulopathies.
- ASA \> II.
- Allergies to tumescent solution components (epinephrine, lidocaine).
- Pregnant or lactating individuals.
- Previous surgeries on the arms.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dhara Clinic
Bogota DC, Bogota DC, 111111, Colombia
Related Publications (4)
Hoyos AE, Perez Pachon ME, Benavides JE, Eljaiek A, Borras Osorio M, Ramirez B. Effects of Optimal Temperature Control in Body Contouring Surgery: A Nonrandomized Controlled Clinical Trial. Aesthet Surg J. 2024 Oct 15;44(11):NP790-NP797. doi: 10.1093/asj/sjae142.
PMID: 38953184BACKGROUNDHoyos A, Perez M. Arm dynamic definition by liposculpture and fat grafting. Aesthet Surg J. 2012 Nov;32(8):974-87. doi: 10.1177/1090820X12461498.
PMID: 23110928BACKGROUNDCala Uribe LC, Perez Pachon ME, Babaitis R, Zannin Ferrero A, Aljure Diaz MF. Variable Energy and Ultrasound-based Liposculpture of the Arms: Multicenter and Multidevice Study. Plast Reconstr Surg Glob Open. 2024 Mar 19;12(3):e5649. doi: 10.1097/GOX.0000000000005649. eCollection 2024 Mar.
PMID: 38948160BACKGROUNDCala Uribe LC, Perez Pachon ME, Zannin Ferrero A, Neri Morales C, Silva Gutierrez J, Manrique Cruz AD, Maza MF, Acero Mondragon EJ, Celis Regalado LG. Effects of Bipolar Radiofrequency on Collagen Synthesis from Patients with Brachial Ptosis. Plast Reconstr Surg Glob Open. 2023 Apr 13;11(4):e4924. doi: 10.1097/GOX.0000000000004924. eCollection 2023 Apr.
PMID: 37063507BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mauricio E Perez Pachon, MD
Total Definer
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Plastic Surgeon
Study Record Dates
First Submitted
March 4, 2025
First Posted
March 10, 2025
Study Start
January 12, 2023
Primary Completion
April 30, 2024
Study Completion
June 30, 2024
Last Updated
March 11, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
There is patient information that cannot be disclosed due to patient preferences.